Literature DB >> 24814742

Diabetes mortality differs between registers due to various disease definitions.

Aneta Aleksandra Nielsen1, Henry Christensen, Erik D Lund, Cramer Christensen, Ivan Brandslund, Anders Green.   

Abstract

INTRODUCTION: We evaluated the impact of including haemolobbing A1c (HbA1c) measurements in a regional algorithm for identification of diabetics by comparing the population identified by the regional algorithm with diabetics registered in the National Danish Diabetes Register (NDR) relative to prevalence, co-morbidity and five-year mortality rate.
MATERIAL AND METHODS: The regional (County of Vejle) and national diabetes populations were compared per the inclusion date of 31 December 2006 limited to persons residing in four municipalities in the County of Vejle, Denmark.
RESULTS: A total of 14,998 diabetics were identified by the regional algorithm, of whom 11,499 (prevalence 4.1%) resided in the four municipalities. The total number of diabetics registered in the NDR was 227,621 in Denmark, of whom 10,976 (prevalence 4.0%) resided in the four municipalities. The regional diabetics (2,802 persons) not identified in the NDR population had a significantly lower mortality rate (57%) than the diabetics (2,279 persons) in the NDR population not identified by the regional algorithm.
CONCLUSION: The significantly higher mortality in the NDR population not identified by the regional algorithm may stem from differences between the components of the two algorithms, i.e. frequency of glucose measurements in the NDR versus frequency of HbA1c measurements including elevated values in the regional algorithm. The NDR algorithm, which includes the use of frequency of glucose measurements without a value over the diagnostic threshold, identified about 21% of persons who probably had their glucose measured for other reasons than diabetes. FUNDING: The Danish Council for Research and Innovation, Region of Southern Denmark's PhD Fund, University of Southern Denmark and the Research Fund, Vejle Hospital. TRIAL REGISTRATION: not relevant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814742

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  5 in total

1.  Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study.

Authors:  Signe S Rasmussen; Nanna B Johansen; Daniel R Witte; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; Marit E Jørgensen
Journal:  Diabetologia       Date:  2016-02-08       Impact factor: 10.122

2.  Validation of the danish national diabetes register.

Authors:  Anders Green; Camilla Sortsø; Peter Bjødstrup Jensen; Martha Emneus
Journal:  Clin Epidemiol       Date:  2014-12-18       Impact factor: 4.790

3.  Using registries to identify type 2 diabetes patients.

Authors:  Reimar W Thomsen; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2014-12-18       Impact factor: 4.790

4.  Vejle Diabetes Biobank - a resource for studies of the etiologies of diabetes and its comorbidities.

Authors:  Eva Rabing Brix Petersen; Aneta Aleksandra Nielsen; Henry Christensen; Torben Hansen; Oluf Pedersen; Cramer Kjeldahl Christensen; Ivan Brandslund
Journal:  Clin Epidemiol       Date:  2016-10-21       Impact factor: 4.790

Review 5.  Erroneous data: The Achilles' heel of AI and personalized medicine.

Authors:  Thomas Birk Kristiansen; Kent Kristensen; Jakob Uffelmann; Ivan Brandslund
Journal:  Front Digit Health       Date:  2022-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.